Matthew Paul Larson - 03 Mar 2026 Form 4 Insider Report for Slide Insurance Holdings, Inc. (SLDE)

Role
Chief Risk Officer
Signature
/s/ Anastasios Omiridis, Attorney-in-Fact for Matthew Larson
Issuer symbol
SLDE
Transactions as of
03 Mar 2026
Net transactions value
-$213,862
Form type
4
Filing time
05 Mar 2026, 19:17:18 UTC
Previous filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
LARSON MATTHEW PAUL Chief Risk Officer 4221 W BOY SCOUT BLVD, SUITE 200, TAMPA /s/ Anastasios Omiridis, Attorney-in-Fact for Matthew Larson 05 Mar 2026 0002114934

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLDE Common Stock Options Exercise +11,250 $0.7900* 11,250 03 Mar 2026 Direct
transaction SLDE Common Stock Sale $213,862 -11,250 -100% $19.01 0 03 Mar 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLDE Stock Option (Right to Buy) Options Exercise -11,250 -13% $0.000000* 76,250 03 Mar 2026 Common Stock 11,250 $0.7900 Direct F2, F3
holding SLDE Stock Option (Right to Buy) 110,000 03 Mar 2026 Common Stock 110,000 $0.7900 Direct F2, F3
holding SLDE Stock Option (Right to Buy) 55,000 03 Mar 2026 Common Stock 55,000 $1.38 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $19.00 to $19.04 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
F2 The exercise price, expiration date and number of stock options reported herein differ from those previously reported on the Reporting Person's Form 3 due to an administrative error. This Form 4 reflects the correct exercise price, expiration date and number of stock options held as of such date.
F3 These stock options are fully vested and exercisable.
F4 Of the 55,000 stock options reported herein, 27,500 are vested and exercisable. The remaining 27,500 vest ratably on July 14, 2026 and July 14, 2027.